Registration Was Closed on Thursday, October 30, 2014 2:00 AM
Waiting List For: Industry Insights- DuPont
Tuesday, October 14, 2014 12:00 PM - 1:30 PM
SoMCC Industry Insights Series: "DuPont: The History of Industrial Biotechnology"
Presented by:
Michael V. Arbige, PhD, Vice President, Research and Development, DuPont Industrial Biosciences
Sponsored by:
School of Medicine Career Center
Presented by:
Michael V. Arbige, PhD, Vice President, Research and Development, DuPont Industrial Biosciences
Sponsored by:
School of Medicine Career Center
Date: Tuesday, October 14, 2014
Time: 12:00-1:30 PM
Location: M114 (Medical Center, Alway building)
*Light lunch will be provided
Overview:
With Genencor’s recent acquisition of DuPont, this collaboration may represent the next big advance in Biotechnology! Unlike most biotechnology companies that focus on developing drugs, DuPont has developed its protein engineering technology to solve industrial problems that directly impact the global sustainability of products.
This talk will cover the history of how DuPont developed the first series of recombinant and protein engineered enzyme products ever to enter the industrial marketplace. These products and those currently under development hold promise to solve global challenges and offer new potential for meeting the world’s demand for food, fuel, materials, while reducing our impact on the environment.
*On-campus Interviews: Act now! DuPont will be conducting on-campus interviews on October 15-16 in the SoMCC offices. Log-in to SciMed and search “DuPont” to apply now!
Speaker bio:
Michael V. Arbige, PhD- Vice President, Research and Development, DuPont Industrial Biosciences
Prior to his current role, Dr. Arbige held the position of executive vice president of Technology, for Genencor, a Danisco Division. Since joining Genencor in 1982, he has served in many roles including senior scientist, director of Fermentation and Process Recovery, vice president of Development, and vice president of Research.He received his Bachelor of Science degree in Microbiology from the University of Rhode Island in 1977 followed by his PhD in 1982 in the field of Microbial Physiology and Genetics from the University of New Hampshire.Dr. Arbige joined Genencor as one of its first employees. During his early tenure at Genencor, Dr. Arbige played a lead role in the development of the first series of recombinant and protein engineered protein products ever to enter the industrial marketplace. Since that time Dr. Arbige has been involved in the commercialization of hundreds of protein based products and has helped establish laboratory and production facilities around the world.
Dr. Arbige currently serves on the boards of Solazyme & Butamax as well as serving for the past 15 years on the board of BayBio, most notably as a past chair and executive member. He is on the technical steering team of DuPont Cellulosic Ethanol and belongs to numerous technical societies including IRI, ACS, ASM, and SIM.
Questions: Email Joe Bucher at:jjbucher@stanford.edu
